| crb®Syphilis Assay is a Point of Care Immunochromatographic in vitro assay used for the qualitative detection of antibodies against Treponema pallidum in human blood samples |
Fast: Test results in 10-20 minutes.
Flexible: Screening of infection using whole blood, serum and plasma
Convenient: Point of Care.
Format: 25 cassettes/Kit (Pack of 240 Kits)| crb® Adenovirus & Rotavirus Assay is a Point of Care, Immunochromatographic test for the qualitative detection of adenovirus and rotavirus in human feces samples |
Fast: Test results in 10-20 minutes.
Flexible: Qualitative detection of Adenovirus and Rotavirus.
Convenient: Point of Care.
Highly Informative: Intra-assay and inter-assay precision have been detected correctly for >99% of the samples.
Format: 25 cassettes/Kit (Pack of 40 Kits)| crb® Zika Assay is a Point of Care Immunochromatographic in vitro assay for the differential detection of IgG & IgM antibodies to Zika virus in human serum, plasma and/or whole blood samples | |
Fast: Test results in 10-20 minutes.
Flexible: Qualitative detection of Zika virus.
Convenient: Point of Care.
Highly Informative: Enables early screening and rapid diagnosis of Zika virus infection.
Format: 25 cassettes/Kit (Pack of 40 Kits)
| crb® Typhoid/Paratyphoid Assay is a Point of Care Immunochromatographic in vitro assay for the qualitative detection of Salmonella Typhi and Paratyphi antigens in human faecal, serum or plasma or whole blood samples
Benefits of crb® Typhoid/Paratyphoid Assay
Fast: Test results in 15-20 minutes. Convenient: Point of Care. Flexible: Qualitative detection of Salmonella Typhi and Paratyphi antigens. Highly Informative: Intra-assay and inter-assay precision have been detected correctly for > 99% of the samples. |
| crb® Trioplex Real-Time RT-PCR Zika/Den/Chiku is a real-time molecular diagnostic test for the screening and differentiation of Zika, dengue and chikungunya virus, extracted from human plasma/serum |
Fast: 2.5 hours from sample to result.
Flexible: Includes internal control (IC) for monitoring of potential PCR inhibitions.
Convenient: Easy reaction setup and result analysis.
Highly Informative: Early detection of Zika, dengue or chikungunya virus infection in a single reaction.
Format: 100 rxns/Kit (Pack of 20 Kits)
| crb® SARS-CoV-2 Assay is a Point of Care Immunochromatographic in vitro assay for the differential detection of IgG & IgM antibodies to SARS-CoV-2 virus in human serum, plasma and/or whole blood samples |
Fast: Test results in 10-20 minutes.
Flexible: Qualitative detection of SARS-CoV-2 virus.
Convenient: Point of Care.
Highly Informative: Enables early screening and rapid diagnosis of SARS-CoV-2 virus infection.
Format: 25 cassettes/Kit (Pack of 40 Kits)| crb® Real-Time RT-PCR Zika kit is a real-time molecular diagnostic test for screening of Zika virus from viral RNA extracted clinical specimens |
Format: 100 rxns/Kit (Pack of 20 Kits)
The crb® SARS-CoV-2 Test provides reliable and high-quality results for clinical decision-making for the improved management of COVID-19 patients and to reduce the risk of SARS-CoV-2 (coronavirus) infection. Healthcare professionals use these tests to assess if patients are at risk of developing disease by this pathogen, which can contribute to severe upper respiratory distress, complications, and potential death. |
A Real-Time molecular test for the screening COVID-19 viral RNA extracted from clinical specimens of the lower respiratory tracts
Benefits of crb® Real-Time RT-PCR SARS-CoV-2
Fast: 2.5 hours from sample to result.
Flexible: Includes internal control (IC) for monitoring of potential PCR inhibitions.
Convenient: Easy reaction setup and result analysis.
Highly Informative: High analytical sensitivity and specificity
| crb® Real-Time RT-PCR MERS-CoV kit is a real-time molecular diagnostic test for the screening of the Middle East respiratory syndrome coronavirus (MERS-CoV) from viral RNA extracted clinical specimens of the lower respiratory tracts |
Fast: 2.5 hours from sample to result.
Flexible: Includes internal control (IC) for monitoring of potential PCR inhibitions.
Convenient: Easy reaction setup and result analysis.
Highly Informative: Sensitive detection of influenza-like viruses.
Format: 100 rxns/Kit (Pack of 50 Kits)
crb® Real-Time RT-PCR Influenza kit is a real-time molecular diagnostic test for the screening and differentiation of seasonal human influenza A and B strains extracted from clinical samples
Benefits of crb® Real-Time RT-PCR Influenza
Fast: 2.5 hours from sample to result.
Flexible: Multiplex and available in different combinations.
Convenient: Easy reaction setup and result analysis.
Highly Informative:
| A Real-Time molecular test for the screening and the differentiation of Influenza A and B strains, COVID-19 and MERS-CoV |
Fast: 2.5 hours from sample to result.
Flexible: Includes internal control (IC) for monitoring of potential PCR inhibitions.
Convenient: Easy reaction setup and result analysis.
Highly Informative: Early detection of Influenza-Like Illnesses (ILI) disease cluster.
Format: 100 rxns/Kit (Pack of 500 Kits)
Format: 100 rxns/Kit (Pack of 50 Kits) 
